BioCircuit Technologies, an Atlanta, GA-based medical device company, raises $9M in Seed funding.
The round was led by Masters Capital, with participation from the GRA Venture Fund and Alsora Capital.
Led by CEO Michelle Jarrard, BioCircuit Technologies develops and commercializes medical devices for tissue repair and neuromodulation that enhance therapeutic targeting, diagnostic precision, and surgical consistency for improved patient outcomes.
The company intends to use the funds to commercialize its nerve repair device, Nerve Tape®, and develop its therapeutic device designed to improve the gait of patients afflicted with spinal cord injuries, stroke, and a variety of other neurological conditions. First human use is scheduled to occur in 2023.
FinSMEs
28/09/2022